SCHEMBL3294289

SCHEMBL3294289

C[C@H]1CN(CCCCN2C(=O)CCC(=O)c3ccccc32)CCN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.47
DRD3 P35462 10/20 0.47
CHRM2 P08172 10/20 0.47
CHRM4 P08173 10/20 0.47
CHRM5 P08912 10/20 0.47
CHRM1 P11229 10/20 0.47
CHRM3 P20309 10/20 0.47
DRD4 P21917 9/20 0.47
GRIN1 Q05586 2/20 0.44
GRIN2B Q13224 2/20 0.44
HTR7 P34969 4/20 0.42
HTR1A P08908 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRA1D P25100 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3291405 1.00 DRD2 (0.47) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3291399 1.00 DRD2 (0.47) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3290421 0.83 DRD2 (0.52) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3289276 0.81 DRD2 (0.49) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3297225 0.81 DRD2 (0.49) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3289284 0.81 DRD2 (0.49) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL5699586 0.80 DRD2 (0.60) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3297695 0.79 DRD3 (0.48) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3292683 0.79 DRD2 (0.58) DRD2DRD3CHRM2CHRM4CHRM5
SCHEMBL3294390 0.79 DRD2 (0.62) DRD2DRD3CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723384-B2 Keto lactam compounds and use thereof ABBOTT GMBH & CO. KG. (DE) 2010-05-25 US disclosed
US-20070219182-A1 Keto Lactam Compounds and Use Thereof ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2007-09-20 US disclosed
EP-1692129-A1 KETO LACTAM COMPOUNDS AND USE THEREOF Abbott GmbH & Co. KG (DE) 2006-08-23 EP disclosed
WO-2005056546-A1 KETO LACTAM COMPOUNDS AND USE THEREOF ABBOTT GMBH & CO. KG (DE) 2005-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219182-A1 Keto Lactam Compounds and Use Thereof OPRD1, DRD3, OPRK1 DRD2 7/4885DRD3 2/4885CHRM2 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.